Back to search

United States· US:39892-0809_40b3cd7d-5f77-2f44-e063-6294a90a46e0

Povidone-Iodine Prep

A povidone-iodine product containing povidone-iodine, registered in United States by O&M HALYARD, INC.. The same ATC class is registered in 12 of our 19 countries.

ATC D08AG02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedPovidone-Iodine PrepATCD08AG02REGISTER NO.US:39892-0809_40b3cd7…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Povidone-iodine is registered in 12 of 19 countries.

Countries holding a registration under ATC D08AG02 (povidone-iodine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Povidone-iodine · ATC D08AG02

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
POVIDONE-IODINE
Manufacturer
O&M HALYARD, INC.
Country
United States (US)
ATC code
D08AG02
ATC class
Povidone-iodine
Defined daily dose
0.4 g, T
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    3989208091
    1.5 mL in 1 PACKET (39892-0809-1)
  • ndc11
    39892-0809-1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for povidone-iodine.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Povidone-iodine · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • LithiumN05AN01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb038b2b-b942-420e-acd9-2d41e3268afe
GET /v1/drugs/cb038b2b-b942-420e-acd9-2d41e3268afe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "100",
  "substance": "POVIDONE-IODINE",
  "productndc": "39892-0809",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "M005",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about povidone-iodine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.